2024
Extracorporeal Shock Wave Therapy Shows Comparative Results With Other Modalities for The Management of Plantar Fasciitis: A Systematic Review and Meta-Analysis
Tung W, Daher M, Covarrubias O, Herber A, Gianakos A. Extracorporeal Shock Wave Therapy Shows Comparative Results With Other Modalities for The Management of Plantar Fasciitis: A Systematic Review and Meta-Analysis. Foot And Ankle Surgery 2024 PMID: 39572278, DOI: 10.1016/j.fas.2024.11.005.Peer-Reviewed Original ResearchEffect of extracorporeal shock wave therapyExtracorporeal shock wave therapyPlantar fasciitisRandomized controlled trialsShock wave therapyManagement of plantar fasciitisMeta-analysisPost intervention VAS scoreTreatment modalitiesWave therapyVAS pain scoresConservative treatment optionsCustom orthoticsHeel painPain scoresSystematic reviewVAS scoreControlled trialsTreatment optionsGoogle ScholarPlaceboFasciitisTherapyModalitiesScoresSex‐specific analysis in patients undergoing Talar OsteoPeriostic grafting from the Iliac Crest (TOPIC) for large osteochondral lesions of the talus
Dahmen J, Gianakos A, Hollander J, Rikken Q, Stufkens S, Kerkhoffs G. Sex‐specific analysis in patients undergoing Talar OsteoPeriostic grafting from the Iliac Crest (TOPIC) for large osteochondral lesions of the talus. Knee Surgery, Sports Traumatology, Arthroscopy 2024, 32: 2679-2687. PMID: 38796727, DOI: 10.1002/ksa.12257.Peer-Reviewed Original ResearchFoot and Ankle Outcome ScoreNumerical rating scaleTopical proceduresClinical outcomesComputed tomographyIliac crestLesion sizeMonths of follow-upPreoperative lesion sizeClinically relevant improvementAnkle Outcome ScorePain scoresNo significant differenceFemale patientsMale patientsConsecutive femalesSex-specific analysesFollow-upTreatment strategiesGraft consolidationOutcome scoresPrimary outcomeAssess consolidationLesion volumeLevel IIIPlatelet-Rich Plasma vs Extracorporeal Shock Wave Therapy in the Treatment of Plantar Fasciitis at 3-6 Months: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Daher M, Covarrubias O, Herber A, Oh I, Gianakos A. Platelet-Rich Plasma vs Extracorporeal Shock Wave Therapy in the Treatment of Plantar Fasciitis at 3-6 Months: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Foot & Ankle International 2024, 45: 796-803. PMID: 38419209, DOI: 10.1177/10711007241231959.Peer-Reviewed Original ResearchPlantar fascia thicknessExtracorporeal shock wave therapyRandomized controlled trialsPlatelet-rich plasmaPlantar fasciitisPlatelet-rich plasma groupShock wave therapyVisual analog scaleFascia thicknessControlled trialsMeta-analysisTreatment of plantar fasciitisExtracorporeal shock wave therapy groupPain scoresWave therapyVisual analog scale painMeta-analysis of randomized controlled trialsEffect of platelet-rich plasmaVAS pain scoresHigher pain reductionManagement of PFFoot disordersSystematic reviewInclusion criteriaPain reductionPlatelet rich plasma therapy versus other modalities for treatment of plantar fasciitis: A systematic review and meta-analysis
Herber A, Covarrubias O, Daher M, Tung W, Gianakos A. Platelet rich plasma therapy versus other modalities for treatment of plantar fasciitis: A systematic review and meta-analysis. Foot And Ankle Surgery 2024, 30: 285-293. PMID: 38395675, DOI: 10.1016/j.fas.2024.02.004.Peer-Reviewed Original ResearchFoot Function IndexPlantar fascia thicknessExtracorporeal shock wave therapyPlantar fasciitisRandomized controlled trialsVisual analog scaleAmerican Orthopaedic Foot and Ankle Society (AOFAS) ankle-hindfoot scorePlatelet-rich plasmaCause of heel painOutcome measuresFoot Function Index scoreTreatment of plantar fasciitisCorticosteroid injectionDextrose prolotherapyMean differenceAnkle-hindfoot scoreMeta-analysisPain scoresShock wave therapyFoot functionFascia thicknessHeel painMusculoskeletal conditionsTrigger pointsManagement of PF
2022
Gender Differences May Exist in the Presentation, Mechanism of Injury and Outcomes Following Bone Marrow Stimulation for Osteochondral Lesions of the Talus
Gianakos A, Williamson E, Mercer N, Kerkhoffs G, Kennedy J. Gender Differences May Exist in the Presentation, Mechanism of Injury and Outcomes Following Bone Marrow Stimulation for Osteochondral Lesions of the Talus. The Journal Of Foot & Ankle Surgery 2022, 62: 75-79. PMID: 35659478, DOI: 10.1053/j.jfas.2022.04.010.Peer-Reviewed Original ResearchConceptsBone marrow stimulationMale patientsFemale patientsPain scoresOsteochondral lesionsMarrow stimulationCartilage repair tissue (MOCART) scoreSymptomatic osteochondral lesionsAnkle Outcome ScoreShort Form-12Mechanism of injuryMagnetic resonance observationYears postsurgeryClinical outcomesOutcome scoresSurgical outcomesRetrospective analysisAnkle biomechanicsPatientsMedial lesionsLateral lesionsLesionsTissue scoresCartilage morphologyOutcomesGender May Affect Mid-Term Outcomes Following Bone Marrow Stimulation for Osteochondral Lesions of the Talus
Gianakos A, Williamson E, Kennedy J. Gender May Affect Mid-Term Outcomes Following Bone Marrow Stimulation for Osteochondral Lesions of the Talus. Foot & Ankle Orthopaedics 2022, 7: 2473011421s00205. PMCID: PMC8794953, DOI: 10.1177/2473011421s00205.Peer-Reviewed Original ResearchBone marrow stimulationMale patientsFemale patientsPain scoresMagnetic resonance imagingOsteochondral lesionsLateral lesionsMarrow stimulationMean MOCART scoreSymptomatic osteochondral lesionsMean patient ageMid-term outcomesAnkle Outcome ScoreShort Form-12Treatment of OLTSignificant differencesCartilage repair tissueConcomitant proceduresPatient ageMagnetic resonance observationClinical outcomesOutcome scoresSurgical interventionMOCART scoreTraumatic etiology
2020
Risk factors for liposomal bupivacaine resistance after total hip or knee arthroplasties: a retrospective observational cohort in 237 patients
Buzin S, Gianakos A, Li D, Viola A, Elkattawy S, Keller D, Yoon R, Liporace F. Risk factors for liposomal bupivacaine resistance after total hip or knee arthroplasties: a retrospective observational cohort in 237 patients. Patient Safety In Surgery 2020, 14: 6. PMID: 32015758, PMCID: PMC6990520, DOI: 10.1186/s13037-020-0230-4.Peer-Reviewed Original ResearchHigher pain scoresLiposomal bupivacainePain scoresRisk factorsPain managementOpioid useYounger patientsRandomized trialsTotal hipKnee arthroplastyRevision arthroplastyMulti-modal pain managementRetrospective observational cohortPain management protocolTotal knee arthroplastyPostoperative painObservational cohortActive smokersOutcomes RegistryInfection/Primary THAResultsA totalRetrospective analysisExclusion criteriaBupivacaine